相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。CHK1 Inhibition Synergizes with Gemcitabine Initially by Destabilizing the DNA Replication Apparatus
Siang-Boon Koh et al.
CANCER RESEARCH (2015)
Molecular Pathways: Overcoming Radiation Resistance by Targeting DNA Damage Response Pathways
Meredith A. Morgan et al.
CLINICAL CANCER RESEARCH (2015)
Molecular Pathways: Targeting ATR in Cancer Therapy
Larry M. Karnitz et al.
CLINICAL CANCER RESEARCH (2015)
Phase I Dose-Escalation Trial of Checkpoint Kinase 1 Inhibitor MK-8776 As Monotherapy and in Combination With Gemcitabine in Patients With Advanced Solid Tumors
Adil I. Daud et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Functional Genetic Screen Identifies Increased Sensitivity to WEE1 Inhibition in Cells with Defects in Fanconi Anemia and HR Pathways
Marieke Aarts et al.
MOLECULAR CANCER THERAPEUTICS (2015)
LY2606368 Causes Replication Catastrophe and Antitumor Effects through CHK1-Dependent Mechanisms
Constance King et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Sensitization of Pancreatic Cancers to Gemcitabine Chemoradiation by WEE1 Kinase Inhibition Depends on Homologous Recombination Repair
Tasneem Kausar et al.
NEOPLASIA (2015)
γH2AX and Chk1 phosphorylation as predictive pharmacodynamic biomarkers of Chk1 inhibitor-chemotherapy combination treatments
Rebecca Rawlinson et al.
BMC CANCER (2014)
Phase I dose-escalation study of AZD7762, a checkpoint kinase inhibitor, in combination with gemcitabine in US patients with advanced solid tumors
Edward Sausville et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2014)
RPA Inhibition Increases Replication Stress and Suppresses Tumor Growth
Jason G. Glanzer et al.
CANCER RESEARCH (2014)
Characterization and preclinical development of LY2603618: a selective and potent Chk1 inhibitor
Constance King et al.
INVESTIGATIONAL NEW DRUGS (2014)
CHEK again: Revisiting the development of CHK1 inhibitors for cancer therapy
S. McNeely et al.
PHARMACOLOGY & THERAPEUTICS (2014)
ATR Prohibits Replication Catastrophe by Preventing Global Exhaustion of RPA
Luis Ignacio Toledo et al.
CELL (2013)
Sensitization of Pancreatic Cancer to Chemoradiation by the Chk1 Inhibitor MK8776
Carl G. Engelke et al.
CLINICAL CANCER RESEARCH (2013)
Cyclin-Dependent Kinase Suppression by WEE1 Kinase Protects the Genome through Control of Replication Initiation and Nucleotide Consumption
Halfdan Beck et al.
MOLECULAR AND CELLULAR BIOLOGY (2012)
Forced Mitotic Entry of S-Phase Cells as a Therapeutic Strategy Induced by Inhibition of WEE1
Marieke Aarts et al.
CANCER DISCOVERY (2012)
Assessment of Chk1 Phosphorylation as a Pharmacodynamic Biomarker of Chk1 Inhibition
Leslie A. Parsels et al.
CLINICAL CANCER RESEARCH (2011)
Gemcitabine Plus nab-Paclitaxel Is an Active Regimen in Patients With Advanced Pancreatic Cancer: A Phase I/II Trial
Daniel D. Von Hoff et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Thierry Conroy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Mechanism of Radiosensitization by the Chk1/2 Inhibitor AZD7762 Involves Abrogation of the G2 Checkpoint and Inhibition of Homologous Recombinational DNA Repair
Meredith A. Morgan et al.
CANCER RESEARCH (2010)
Chk1 inhibition after replicative stress activates a double strand break response mediated by ATM and DNA-dependent protein kinase
Samuel McNeely et al.
CELL CYCLE (2010)
Focus on histone variant H2AX: To be or not to be
Jingsong Yuan et al.
FEBS LETTERS (2010)
Enhanced H2AX Phosphorylation, DNA Replication Fork Arrest, and Cell Death in the Absence of Chk1
Mary E. Gagou et al.
MOLECULAR BIOLOGY OF THE CELL (2010)
Chk1 promotes replication fork progression by controlling replication initiation
Eva Petermann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Claspin and Chk1 regulate replication fork stability by different mechanisms
Jennifer Scorah et al.
CELL CYCLE (2009)
The decision to enter mitosis: feedback and redundancy in the mitotic entry network
Arne Lindqvist et al.
JOURNAL OF CELL BIOLOGY (2009)
Gemcitabine sensitization by checkpoint kinase 1 inhibition correlates with inhibition of a Rad51 DNA damage response in pancreatic cancer cells
Leslie A. Parsels et al.
MOLECULAR CANCER THERAPEUTICS (2009)
The combination of epidermal growth factor receptor inhibitors with gemcitabine and radiation in pancreatic cancer
Meredith A. Morgan et al.
CLINICAL CANCER RESEARCH (2008)
AZD7762, a novel checkpoint kinase inhibitor, drives checkpoint abrogation and potentiates DNA-targeted therapies
Sonya D. Zabludoff et al.
MOLECULAR CANCER THERAPEUTICS (2008)
H2AX phosphorylation marks gemcitabine-induced stalled replication forks and their collapse upon S-phase checkpoint abrogation
Brett Ewald et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Pharmacological abrogation of S-phase checkpoint enhances the anti-tumor activity of gemcitabine in vivo
David J. Matthews et al.
CELL CYCLE (2007)
The relationship of premature mitosis to cytotoxicity in response to checkpoint abrogation and antimetabolite treatment
Meredith A. Morgan et al.
CELL CYCLE (2006)
Role of checkpoint kinase 1 in preventing premature mitosis in response to gemcitabine
MA Morgan et al.
CANCER RESEARCH (2005)
Inhibition of human Chk1 causes increased initiation of DNA replication, phosphorylation of ATR targets, and DNA breakage
RG Syljuåsen et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
The cell-cycle checkpoint kinase Chk1 is required for mammalian homologous recombination repair
CS Sorensen et al.
NATURE CELL BIOLOGY (2005)
DNA damage-induced mitotic catastrophe is mediated by the Chk1-dependent mitotic exit DNA damage checkpoint
XX Huang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Targeting the checkpoint kinases: Chemosensitization versus chemoprotection
BBS Zhou et al.
NATURE REVIEWS CANCER (2004)
Chk1 regulates the S phase checkpoint by coupling the physiological turnover and ionizing radiation-induced accelerated proteolysis of Cdc25A
CS Sorensen et al.
CANCER CELL (2003)
Activation of mammalian Chk1 during DNA replication arrest: a role for Chk1 in the intra-S phase checkpoint monitoring replication origin firing
C Feijoo et al.
JOURNAL OF CELL BIOLOGY (2001)
分享论文
